REQUEST A DEMO
Total
USD $0.00
Search more companies

Merz Asia Pacific Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Merz Asia Pacific Pte. Ltd. Profile Updated: August 29, 2019
Buy our report for this company USD 19.99 Most recent financial data: 2018 Available in: English Download a sample report

Merz Asia Pacific Pte. Ltd. is engaged in wholesale distribution of prescription drugs, over-the-counter medicines, and related products. The company was incorporated in 2010 and is based in Singapore.

Headquarters
21 Biopolis Road #06-03/04 Nucleos Singapore 138567
Singapore; Singapore; Postal Code: 138567

Contact Details: Purchase the Merz Asia Pacific Pte. Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Merz Asia Pacific Pte. Ltd. report to view the information.
Registered Capital:
Purchase the Merz Asia Pacific Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Merz Asia Pacific Pte. Ltd. report to view the information.
Incorporation Date:
August 20, 2010
Key Executives
Purchase this report to view the information.
Chairman/Director
Purchase this report to view the information.
Chairman/Director
Purchase this report to view the information.
Chairman/Director
Purchase this report to view the information.
Chairman/Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
Subsidiaries
Merz Healthcare (Thailand) Company Limited (Thailand)
Company Performance
Financial values in the chart are available after Merz Asia Pacific Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Total operating revenue
2.94%
Net Profit (Loss) for the Period
-86.78%
Total assets
6.43%
Total equity
6.62%
Return on Equity (ROE)
-49.82%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?